CD79A and rheumatoid arthritis: By contrast, in studies that reported no association between the aB2GP1 IgA in autoimmune populations, the prevalence of aB2GP1 IgA was about 29% in patients with Rheumatoid Arthritis and ranged between 6–25% in patients with SLE.